Sino Biopharmaceutical (SBMFF) Income Statement

44 Followers

Sino Biopharmaceutical Income Statement

Last quarter (Q2 2026), Sino Biopharmaceutical's total revenue was ¥9.72B, an increase of 10.64% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was ¥1.72B. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 31.83B	¥ 28.87B	¥ 26.20B	¥ 26.03B	¥ 26.86B
Gross Profit	¥ 26.13B	¥ 23.53B	¥ 21.21B	¥ 21.54B	¥ 21.53B
Operating Expenses	¥ 19.17B	¥ 17.39B	¥ 15.54B	¥ 15.95B	¥ 17.19B
Depreciation and Amortization	¥ 963.90M	¥ 939.85M	¥ 1.07B	¥ 1.05B	¥ 992.56M
EBITDA	¥ 7.26B	¥ 6.11B	¥ 6.98B	¥ 6.69B	¥ 19.87B
Operating Income	¥ 6.95B	¥ 6.14B	¥ 5.79B	¥ 5.59B	¥ 5.08B
Other Income/Expenses	¥ -10.21M	¥ -858.09M	¥ -375.81M	¥ -370.95M	¥ 13.49B
Pretax Income	¥ 6.94B	¥ 5.28B	¥ 5.41B	¥ 5.21B	¥ 18.57B
Net Income	¥ 2.34B	¥ 3.50B	¥ 2.33B	¥ 2.54B	¥ 14.61B
Per Share Metrics
Basic EPS	¥ 0.13	¥ 0.20	¥ 0.10	¥ 0.11	¥ 0.78
Diluted EPS	¥ 0.13	¥ 0.19	¥ 0.10	¥ 0.12	¥ 0.73
Weighted Average Shares Outstanding	18.05B	17.24B	18.53B	18.62B	18.77B
Weighted Average Shares Outstanding (Diluted)	18.06B	18.30B	18.53B	19.02B	19.28B

Currency in CNY

Sino Biopharmaceutical (SBMFF) Income Statement

Sino Biopharmaceutical Income Statement

Sino Biopharmaceutical Earnings and Revenue History